WWOX developmental and epileptic encephalopathy: Understanding the epileptology and the mortality risk.
WWOX
EIDEE
early infantile developmental and epileptic encephalopathy
epileptic spasms
genotype-phenotype correlation
survival probability
Journal
Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
revised:
08
02
2023
received:
24
08
2022
accepted:
09
02
2023
medline:
11
5
2023
pubmed:
14
2
2023
entrez:
13
2
2023
Statut:
ppublish
Résumé
WWOX is an autosomal recessive cause of early infantile developmental and epileptic encephalopathy (WWOX-DEE), also known as WOREE (WWOX-related epileptic encephalopathy). We analyzed the epileptology and imaging features of WWOX-DEE, and investigated genotype-phenotype correlations, particularly with regard to survival. We studied 13 patients from 12 families with WWOX-DEE. Information regarding seizure semiology, comorbidities, facial dysmorphisms, and disease outcome were collected. Electroencephalographic (EEG) and brain magnetic resonance imaging (MRI) data were analyzed. Pathogenic WWOX variants from our cohort and the literature were coded as either null or missense, allowing individuals to be classified into one of three genotype classes: (1) null/null, (2) null/missense, (3) missense/missense. Differences in survival outcome were estimated using the Kaplan-Meier method. All patients experienced multiple seizure types (median onset = 5 weeks, range = 1 day-10 months), the most frequent being focal (85%), epileptic spasms (77%), and tonic seizures (69%). Ictal EEG recordings in six of 13 patients showed tonic (n = 5), myoclonic (n = 2), epileptic spasms (n = 2), focal (n = 1), and migrating focal (n = 1) seizures. Interictal EEGs demonstrated slow background activity with multifocal discharges, predominantly over frontal or temporo-occipital regions. Eleven of 13 patients had a movement disorder, most frequently dystonia. Brain MRIs revealed severe frontotemporal, hippocampal, and optic atrophy, thin corpus callosum, and white matter signal abnormalities. Pathogenic variants were located throughout WWOX and comprised both missense and null changes including five copy number variants (four deletions, one duplication). Survival analyses showed that patients with two null variants are at higher mortality risk (p-value = .0085, log-rank test). Biallelic WWOX pathogenic variants cause an early infantile developmental and epileptic encephalopathy syndrome. The most common seizure types are focal seizures and epileptic spasms. Mortality risk is associated with mutation type; patients with biallelic null WWOX pathogenic variants have significantly lower survival probability compared to those carrying at least one presumed hypomorphic missense pathogenic variant.
Substances chimiques
WWOX protein, human
EC 1.1.1.-
WW Domain-Containing Oxidoreductase
EC 1.1.1.-
Tumor Suppressor Proteins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1351-1367Informations de copyright
© 2023 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
Références
Eur J Hum Genet. 2016 Jun;24(6):949-53
pubmed: 26486474
J Med Genet. 1993 Nov;30(11):932-6
pubmed: 8301648
Brain. 2021 Nov 29;144(10):3061-3077
pubmed: 33914858
Front Neurosci. 2020 Jun 11;14:644
pubmed: 32581702
Epileptic Disord. 2020 Feb 1;22(1):120-124
pubmed: 32051108
Epilepsia. 2017 Apr;58(4):522-530
pubmed: 28276060
Brain. 2007 Jul;130(Pt 7):1921-8
pubmed: 17470496
J Med Genet. 2022 Aug;59(8):748-758
pubmed: 34740920
Epilepsia. 2017 Apr;58(4):512-521
pubmed: 28276062
Neurol Genet. 2022 May 31;8(3):e676
pubmed: 35655584
Science. 1974 Sep 6;185(4154):862-4
pubmed: 4843792
Dev Med Child Neurol. 2023 Jan;65(1):50-57
pubmed: 35701389
Genet Med. 2019 Jun;21(6):1308-1318
pubmed: 30356099
J Mol Neurosci. 2015 May;56(1):17-23
pubmed: 25403906
Orphanet J Rare Dis. 2014 Jan 23;9:12
pubmed: 24456803
Hum Mutat. 2011 Dec;32(12):1500-6
pubmed: 21850686
Front Pediatr. 2022 Apr 29;10:847549
pubmed: 35573960
Lancet Neurol. 2016 Mar;15(3):304-16
pubmed: 26597089
Epilepsia. 2023 May;64(5):1368-1375
pubmed: 36808730
Curr Opin Neurol. 2020 Apr;33(2):179-184
pubmed: 32049741
Neurol Res. 2021 Sep;43(9):744-750
pubmed: 34034642
Transl Neurosci. 2018 Dec 31;9:203-208
pubmed: 30746283
Epileptic Disord. 2018 Oct 1;20(5):401-412
pubmed: 30361190
Ann Neurol. 2019 Dec;86(6):821-831
pubmed: 31618474
Brain. 2014 Feb;137(Pt 2):411-9
pubmed: 24369382
Int J Ayurveda Res. 2010 Oct;1(4):274-8
pubmed: 21455458
F1000Res. 2020 Mar 12;9:
pubmed: 32201576
Am J Med Genet A. 2015 Dec;167A(12):3209-13
pubmed: 26345274
Exp Cell Res. 2014 Nov 15;329(1):85-93
pubmed: 25281304
Epilepsia. 2023 May;64(5):1351-1367
pubmed: 36779245
Epilepsia. 2019 Aug;60(8):1733-1742
pubmed: 31313283
BMC Med Genet. 2016 Aug 05;17(1):53
pubmed: 27495153
Int J Mol Sci. 2019 Jul 23;20(14):
pubmed: 31340538
Acta Neuropathol Commun. 2020 Jan 30;8(1):6
pubmed: 32000863
Neurogenetics. 2018 Aug;19(3):151-156
pubmed: 29808465
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):3949-54
pubmed: 17360458
Int J Dev Neurosci. 2019 Dec;79:45-48
pubmed: 31669195
Epilepsia. 2022 Jun;63(6):1398-1442
pubmed: 35503717
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
Neurology. 2021 Oct 26;97(17):817-831
pubmed: 34493617
Annu Rev Genet. 2007;41:169-92
pubmed: 17608616
J Med Genet. 2015 Jan;52(1):61-70
pubmed: 25411445
Cancer Res. 2001 Nov 15;61(22):8068-73
pubmed: 11719429
J Hum Genet. 2015 May;60(5):267-71
pubmed: 25716914
Eur J Paediatr Neurol. 2019 May;23(3):418-426
pubmed: 30853297
Epilepsia. 2022 Jun;63(6):1349-1397
pubmed: 35503712
J Med Genet. 2018 Dec;55(12):803-813
pubmed: 30287594
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11417-22
pubmed: 11572989
Int J Dev Neurosci. 2020 Apr;80(2):157-161
pubmed: 32037574
Cancer Res. 2002 Apr 15;62(8):2258-60
pubmed: 11956080
Neurol Sci. 2018 Nov;39(11):1977-1980
pubmed: 30094525